These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19294570)

  • 21. The development of complications in patients with chronic anterior uveitis.
    Menezo V; Lightman S
    Am J Ophthalmol; 2005 Jun; 139(6):988-92. PubMed ID: 15953427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psoriatic uveitis: a distinct clinical entity?
    Durrani K; Foster CS
    Am J Ophthalmol; 2005 Jan; 139(1):106-11. PubMed ID: 15652834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
    Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
    Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
    Tabbara KF; Al-Hemidan AI
    Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment].
    Paire V; Lebreton O; Weber M
    J Fr Ophtalmol; 2010 Mar; 33(3):152-62. PubMed ID: 20181409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comment on 'Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics'.
    Rothova A
    Ocul Immunol Inflamm; 2000 Mar; 8(1):73-5. PubMed ID: 10896457
    [No Abstract]   [Full Text] [Related]  

  • 27. Ocular signs predictive of tubercular uveitis.
    Gupta A; Bansal R; Gupta V; Sharma A; Bambery P
    Am J Ophthalmol; 2010 Apr; 149(4):562-70. PubMed ID: 20149341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases.
    Monnet D; Breban M; Hudry C; Dougados M; Brézin AP
    Ophthalmology; 2004 Apr; 111(4):802-9. PubMed ID: 15051216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ranibizumab for refractory uveitis-related macular edema.
    Acharya NR; Hong KC; Lee SM
    Am J Ophthalmol; 2009 Aug; 148(2):303-309.e2. PubMed ID: 19427988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis.
    Murphy CC; Greiner K; Plskova J; Frost NA; Forrester JV; Dick AD
    Br J Ophthalmol; 2007 Feb; 91(2):154-6. PubMed ID: 16973657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome.
    Williams GA; Haller JA; Kuppermann BD; Blumenkranz MS; Weinberg DV; Chou C; Whitcup SM;
    Am J Ophthalmol; 2009 Jun; 147(6):1048-54, 1054.e1-2. PubMed ID: 19268890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Profile of HLA B-27-Associated Uveitis Patients in a Tertiary Care Eye Hospital in Eastern India.
    Majumdar AK; Kumar A; Roy R; Dutta Majumder P
    Ocul Immunol Inflamm; 2019; 27(5):718-721. PubMed ID: 30010461
    [No Abstract]   [Full Text] [Related]  

  • 33. High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study.
    Mohammadi M; Shahram F; Shams H; Akhlaghi M; Ashofteh F; Davatchi F
    Int J Rheum Dis; 2017 Sep; 20(9):1269-1276. PubMed ID: 28524639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).
    Davatchi F; Shams H; Rezaipoor M; Sadeghi-Abdollahi B; Shahram F; Nadji A; Chams-Davatchi C; Akhlaghi M; Faezi T; Naderi N
    Int J Rheum Dis; 2010 Aug; 13(3):246-52. PubMed ID: 20704622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe HLA B27-associated uveitis complicated by hypotony, serous retinal detachment, and ciliochoroidal effusion.
    van der Veer EG; Keunen JE; Rothova A
    Ocul Immunol Inflamm; 2014 Feb; 22(1):23-6. PubMed ID: 24063542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis.
    Androudi S; Brazitikos P; Iaccheri B; Fiore T; Christen W; Meniconi M; Foster CS
    Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1000-5. PubMed ID: 14605907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of laser flare photometry to assess and monitor inflammation in uveitis.
    Herbort CP; Guex-Crosier Y; de Ancos E; Pittet N
    Ophthalmology; 1997 Jan; 104(1):64-71; discussion 71-2. PubMed ID: 9022106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Birdshot retinochoroidopathy].
    Cassoux N; Lehoang P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S45-7. PubMed ID: 10896989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
    Lopez-Gonzalez R; Loza E; Jover JA; Benitez Del Castillo JM; Mendez R; Hernandez-Garcia C; Pato E
    Scand J Rheumatol; 2009; 38(1):58-62. PubMed ID: 18991187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-B27-associated uveitis with a chorioretinitis manifestation.
    Lin JY; Lin SL; Chen WL; Chen YS
    Ophthalmic Surg Lasers Imaging; 2005; 36(2):158-62. PubMed ID: 15792320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.